¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phage cross"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross neutralization
    ±³Â÷ÁßÈ­
  • cross reactivation
    ±³Â÷ÀçȰ¼ºÈ­
  • cross relaxation
    ±³Â÷ÀÌ¿Ï
  • cross section radiography
    ´ÜÃþ¹æ»ç¼±ÃÔ¿µ(¼ú)
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • cross sensitization
    ±³Â÷¹Î°¨È­
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross training
    ±³Â÷ÈÆ·Ã
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
  • cross-contamination
    ±³Â÷¿À¿°
  • cross-cultural psychiatry
    ¹®È­ºñ±³Á¤½ÅÀÇÇÐ
  • cross-dressing
    ÀÇ»óµµÂøÁõ
  • cross-face
    ±³Â÷¾ó±¼
  • cross-finger
    ±³Â÷¼Õ°¡¶ô
  • cross-finger flap
    ±³Â÷¼Õ°¡¶ôÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-linking
    ±³Â÷°áÇÕ
  • cross-plate
    ±³Â÷ÆÇ
  • cross-protection
    ±³Â÷¹æ¾î
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cross-reactivity
    ±³Â÷¹ÝÀÀ¼º
  • cross-resistance
    ±³Â÷ÀúÇ×
  • cross-section
    °¡·Î´Ü¸é
  • cross-talk
    ±³Â÷´ëÈ­
  • cross-tolerance
    ±³Â÷³»¼º
  • cross-validation
    ±³Â÷Ÿ´çµµ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross examination
    ±³Â÷°Ë»ç
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • phage, transducing
    ÇüÁúµµÀÔÆÄÁö
  • phage, vegetative
    Áõ½ÄÇüÆÄÁö
  • phage, virulent
    ¿ë±Õ¼ºÆÄÁö, µ¶¼ºÆÄÁö
  • temperate phage
    ÀáÀ缺ÆÄÁö, ¿Â¼øÆÄÁö
  • temperate phage
    ÀáÀ缺(íÖî¤àõ) ÆÄ¾ÆÁö
  • temperate phage
    ÀáÀ缺 ÆÄÁö, ¿Â¼øÆÄÁö
  • temperature sensitive phage
    ¿Âµµ¹Î°¨¼º(è®öôÚÂÊïàõ)ÆÄÁö.
  • temperature-sensitive phage
    ¿Âµµ¹Î°¨ÆÄÁö
  • transducing phage
    ÇüÁúµµÀÔ(û¡òõÓôìý) ÆÄÁö.
  • type, phage
    ÆÄÁöÇü
  • vegetative phage
    Áõ½ÄÇüÆÄÁö
  • virulent phage
    ¿ë±Õ¼º ÆÄÁö, µ¶¼º ÆÄÁö
  • virulent phage
    µ¶¼º(Ô¸àõ)ÆÄÁö.
  • absorption, cross
    ±³Â÷Èí¼ö½ÃÇè
  • antibody, cross-reacting
    ±³Â÷¹ÝÀÀÇ×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-electrophoresis
    ±³Â÷Àü±â¿µµ¿(Îßó©ï³Ñ¨ç¶ÔÑ)
  • cross-hybridization
    ±³Â÷(Îßó©)Æ¢±â Çü¼º(û¡à÷)
  • cross-induction
    ±³Â÷À¯µµ(Îßó©ë¯Óô)
  • cross-infection
    ±³Â÷°¨¿°(Îßó©Êïæø)
  • cross-linker
    ±³Â÷¿¬°èÀÚ(Îßó©ææÍ¨í­)
  • cross-linking
    ±³Â÷¿¬°è(Îßó©ææÍ¨)
  • cross-matching
    ±³Â÷ÀûÇÕ°Ë»ç(Îßó©îêùêËþÞÛ)
  • cross-partition
    ±³Â÷ºÐ¹è(Îßó©ÝÂÛÕ)
  • cross-reacting antibody
    ±³Â÷¹ÝÀÀ Ç×ü(Îßó©Úãëëù÷ô÷)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BCBSA Blue Cross and Blue Shield Association
BCP basic calcium phosphate; birth control pill; blue cone pigment; Blue Cross Plan; bromcresol purple
BIP bacterial intravenous protein; biparietal; bismuth iodoform paraffin; Blue Cross interim payment; br...
BRCS British Red Cross Society
CCCE cross-cultural cognitive examination
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CP Cross-polarization
CRM Cross-reacting material
CRI Cross-reactive idiotypes
X-SA Cross-sectional area
CSMI Cross-sectional moment of inertia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross-over position
    ¹Ý´ëÀ§
  • cross-reactivity
    ±³Â÷ ¹ÝÀÀ¼º
  • cross-section
    Ⱦ´Ü ¸é
    ¾î´À ½ÃÆíÀÇ ³»ºÎ¸¦ °üÂûÇϱâ À§ÇÏ¿© ÀϹÝÀûÀ¸·Î Á߽ɺθ¦ Ⱦ´Ü½ÃÄÑ °¡·Î ¶Ç´Â ¼¼·Î·Î ÀÚ¸¥ ¸é.
  • cross-sectional sample
    ȾÀûÀÎ °æ¿ì
  • cross-sectional study
    Ⱦ´Ü ¿¬±¸¹ý, Ⱦ´Ü Á¶»ç¹ý
  • posterior cross bite
    ±¸Ä¡ ¹Ý´ë±³ÇÕ, ±¸Ä¡ºÎ ¹Ý´ë±³ÇÕ
  • sagittal cross section
    ½Ã»ó´Ü
    ½Ã»ó¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
cross flap A skin flap transferred from one part of the body to a corresponding part, as from one arm to the other.
(05 Mar 2000)
cross-hybridisation <molecular biology> The hydrogen bonding of asingle-stranded DNA sequence that is partially but not entirely complementary to a single-stranded substrate. Often, this involves hybridising a DNA probe for a specific DNA sequence to the homologous sequences of different species.
(09 Oct 1997)
cross hybridization Annealing of a DNA probe to an imperfectly matching DNA molecule.
(05 Mar 2000)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cross-link A covalent linkage between two polymers or between two different regions of the same polymer.
(05 Mar 2000)
cross linking 1. <chemistry> The linking of the chains of a polymer to one another so that the polymer, as a network, becomes stronger and more resistant to being dissolved.
2. <molecular biology> The abnormal linking of two strands of DNA by covalent bonds (as opposed to the normal hydrogen bonds between base pairs), which can occur by exposure to X-rays. Such linking is a type of damage to the DNA molecule and must be repaired before the DNA can replicate and function properly again.
(09 Oct 1997)
cross-linking reagent <chemistry> Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
(12 Dec 1998)
cross-matching 1. A test for incompatibility between donor and recipient blood, carried out prior to transfusion to avoid potentially lethal haemolytic reactions between the donor's red blood cells and antibodies in the recipient's plasma, or the reverse; performed by mixing a sample of red blood cells of the donor with plasma of the recipient (major crossmatch) and the red blood cells of the recipient with the plasma of the donor (minor crossmatch). Incompatibility is indicated by clumping of red blood cells and contraindicates use of the donor's blood.
2. In allotransplantation of solid organs (e.g., kidney), a test for identification of antibody in the serum of potential allograft recipients which reacts directly with the lymphocytes or other cells of a potential allograft donor; presence of these antibodies usually, if not always, contraindicates the performance of the transplantation because virtually all such grafts will be subject to a hyperacute type of rejection.
(05 Mar 2000)
cross-pollination <botany> Fertilization of a plant from a plant with a different genetic makeup.
(09 Oct 1997)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
cross reaction <haematology, immunology> Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
(12 Dec 1998)
cross-reactive antibody <haematology, immunology> Antibodies which don't respond to any one specific antigen, but will respond to a number of them. These antibodies can be responsible for false positive results in antigen-antibody tests.
(09 Oct 1997)
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • cross bun
    ½ÊÀÚ ¹«´Ì·Î ´çÀǸ¦ ÀÔÈù °úÀÚ »§
  • cross counter
    Å©·Î½ºÄ«¿îÅÍ(»ó´ë¹æ °ø°Ý¿¡ ´ëÇØ ±³Â÷ÀûÀ¸·Î °¡ÇÏ´Â ¹Ý°Ý)
  • cross current
    ¿ª·ù;´ë¸³ÇÏ´Â °æÇâ
  • cross cut
    °¡·Î ÄÑ´Â (Åé);°¡·Î ÀÚ¸¥;»û±æ;Áö¸§±æ;(Àç¸ñÀÇ)°¡·ÎÄѱâ;ȰÁÖÇüÀÇ ÀÏÁ¾(½ºÄÉÀÌÆ®);°¡·ÎÄÑ´Ù;°¡·ÎÁö¸£´Ù;~ter
  • cross fire
    ½ÊÀÚÆ÷È­;(Áú¹®ÀÇ)ÀÏÁ¦ °ø¼¼;(¸»ÀÇ)°Ý·ÄÇÑ ÀÀ¼ö;Ç÷¹ÀÌÆ®ÀÇ °¢À» ÁÇ·Î °¡·ÎÁö¸£´Â Åõ±¸
  • cross grain
    ¾ù°á
  • cross hairs
    (¸Á¿ø°æ µîÀÇ ÃÐÁ¡¿¡ »ý±ä)½ÊÀÚ¼±
  • cross keys
    2 °³ÀÇ ¿­¼è°¡ ±³Â÷ÇÑ ¹®Àå(·Î¸¶ ±³È²ÀÇ)
  • cross license
    »óÈ£ ƯÇã »ç¿ë Çã°¡
  • cross matching
    ±³Â÷(ÀûÇÕ)½ÃÇè
  • cross multiply
    µÎ ºÐ¼öÀÇ °¢°¢ÀÇ ºÐÀÚ¿¡ ´Ù¸¥ ºÐ¼öÀÇ ºÐ¸ð¸¦ °öÇÏ´Ù
  • cross rate
    Å©·Î½º ·¹ÀÌÆ®;¿µ.¹Ì ȯ½Ã¼¼
  • cross sea
    ³î;¿ªÇ³¶û
  • cross section
    °¡·ÎÀÚ¸£±â;Ⱦ´Ü¸é;´Ü¸éµµ;(»çȸ µîÀÇ)´ëÇ¥ÀûÀÎ ¸é;´Ü¸é
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á